Carmen P. Montano‐Almendras

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

Christian Winther Eskelund, Christina Dahl, Jakob Werner Hansen et al. · Blood · 2017 · 396 citations · Full text

Medicine, Hematology, Oncology +14

Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis.

Jean‐Baptiste Demoulin, Carmen P. Montano‐Almendras · PubMed · 2012 · 84 citations · Full text

Medicine, Cell Biology, Hematology +17

PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations

Amélie I. Velghe, Stéphane Van Cauwenberghe, Anton A. Polyansky et al. · Oncogene · 2013 · 81 citations

Medicine, Molecular Biology, Oncology +15

<i>PRDM16</i> (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies

François P. Duhoux, Geneviève Ameye, Carmen P. Montano‐Almendras et al. · British Journal of Haematology · 2011 · 58 citations

Medicine, Hematology, Molecular Genetics +14

ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor- B

Carmen P. Montano‐Almendras, Ahmed Essaghir, Hélène Schoemans et al. · Haematologica · 2012 · 53 citations · Full text

Medicine, Cell Biology, Hematology +17